Shannon M MacDonald (@shannonmacdonmd) 's Twitter Profile
Shannon M MacDonald

@shannonmacdonmd

@MassGeneralBrigham oncology specialist in proton therapy. Yoga, ocean, sailing/boating, outdoors, friends, family, my dog. @HarvardMed

ID: 1543728720778756096

calendar_today03-07-2022 22:49:54

191 Tweet

827 Followers

598 Following

Akila Viswanathan MD (@anviswanathanmd) 's Twitter Profile Photo

Seminars in Radiation Oncology Elsevier is pleased to share "Future of Telemedicine in Radiation Oncology" by Dr. Sean M. McBride Sean McBride, Dr Helen K. Hughes Johns Hopkins Medicine, Dr. Shannon M. MacDonald Shannon M MacDonald sciencedirect.com/science/articl…

John Suh (@drjohnsuh) 's Twitter Profile Photo

Looking forward to ⁦Erin Murphy MD⁩ talk on neoadjuvant radiosurgery for brain metastases during the 25th Annual Brain Tumor Update & 14th Annual Symposium on Brain Metastases & Spine Tumors in Los Angeles. ⁦Keck Medicine of USC⁩ ⁦Cleveland Clinic MD

Looking forward to ⁦<a href="/ErinMurphyMD/">Erin Murphy MD</a>⁩ talk on neoadjuvant radiosurgery for brain metastases during the 25th Annual Brain Tumor Update &amp; 14th Annual Symposium on Brain Metastases &amp; Spine Tumors in Los Angeles. ⁦<a href="/KeckMedicineUSC/">Keck Medicine of USC</a>⁩ ⁦<a href="/CleClinicMD/">Cleveland Clinic MD</a>⁩
Amy Comander MD, DipABLM (@dramycomander) 's Twitter Profile Photo

At #LM2024, Dana Haggett CNP presented data re: the impact of the PAVING the Path to Wellness Program for breast cancer survivors on adopting healthy behaviors after a cancer diagnosis.MGHBreastOnc Mass General Cancer Center MGH Breast Oncology Paving the Path to Wellness healio.com/news/primary-c…

Carmel Shachar (@carmelshachar) 's Twitter Profile Photo

Many hot takes on what the election means for health policy, but I think it's important to put the second Trump administration in the context of weakening respect for expertise, especially when it comes to doctors. My thoughts in STAT

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Just a reminder that in the US, most large RCTs of radiation are NCI-sponsored (no pharma $). No NCI funding, no RT trials. If goal of pause is to assess & re-prioritize funding across oncology sectors including RT, I know many of us would be happy to share ideas re how.

Sean McBride (@seanmmcbride) 's Twitter Profile Photo

This was the date set in the end of year (2024) appropriations bill passed by the prior Congress and signed by President Biden. This new Congress was always going to have to provide for a statutory extension. We knew this in December. I’m confident Congress will act. Our

Sean McBride (@seanmmcbride) 's Twitter Profile Photo

A great question! And one currently being litigated in two federal appeals courts, at least as it applies to inter-state telehealth. Broadly speaking, in the inter-state telehealth setting, specifically w/r/t consultations, we've argued that the requirement that already

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Come on #ASCO25, this 💯 should have been a plenary! 7% improvement in 8-yr OS w exercise in adjuvant colon ca, greater than benefit for adding oxali to 5-FU (5% at 10 yrs in MOSAIC). Exercise = $ effective, ~0 tox, & gives pts sense of empowerment. Congrats Chris Booth et al!

Myrsini Ioakeim-Ioannidou, MD (@myrsiniioakeim) 's Twitter Profile Photo

Excited to be in Buenos Aires for #PTCOG63! Thank you The Particle Therapy Co-Operative Group (PTCOG) for the honor to moderate the CNS/Sarcoma session — join us Friday at 230pm for a great lineup of presentations and discussion. See you there! ☢️🇦🇷✨

Excited to be in Buenos Aires for #PTCOG63! Thank you <a href="/PTCOG_Official/">The Particle Therapy Co-Operative Group (PTCOG)</a> for the honor to moderate the CNS/Sarcoma session — join us Friday at 230pm for a great lineup of presentations and discussion. See you there! ☢️🇦🇷✨
Shannon M MacDonald (@shannonmacdonmd) 's Twitter Profile Photo

Patients with recurrent disease had improved OS and decreased lymphopenia in proton arm suggesting these patients were more likely to tolerate treatment and be salvaged after relapse if they received proton RT.

Josh Sommer (@sommerjo) 's Twitter Profile Photo

Excited to add this role to the CF team. The aim is to expand the pipeline of therapies in development for chordoma by allowing us to support and collaborate with more investigators and companies, and drive more research on our own through CF Labs and CRO partners.